透過您的圖書館登入
IP:3.134.253.166
  • 學位論文

黃芩之安胎作用研究

Tocolytic Effects of Scutellaria baicalensis in Rat Uterus

指導教授 : 楊玲玲 教授 許淳森 副教授
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


使用中藥及處方治療疾病在中國已有幾千年的歷史。黃芩(Huang Qin) 唇形科(Labiatae) 植物Scutellaria baicalensis Georgi之乾燥根,為中藥安胎方劑常配伍之中藥材,但卻無相關之科學化研究。本研究第一部份首先以現代藥理學之技術,評估黃芩水抽出物及其成分Baicalin、Baicalein、Oroxylin A、Wogonin之安胎作用,發現黃芩水抽取物高劑量時對懷孕初期(第10天) 離體雌性大白鼠子宮平滑肌收縮有意義抑制作用,IC50為4.98 + 1.12 mg/ml,由結果證實,黃芩具有安胎活性物質。因此乃再進行四種黃芩成分Baicalin、Baicalein、Oroxylin A、Wogonin 對懷孕初期(第10天)離體子宮平滑肌之收縮抑制作用,IC50分別為67.22 + 5.75μM,59.71 + 6.67μM,50.38 + 4.91μM,71.11 + 5.11μM,證實此四種flavonoid類成分具有安胎活性。繼而進行第二部份四種活性主成分之作用機制探討。 黃芩成分對Acetylcholine ( ACh;10-6 M ),Prostaglandin F2a ( PGF2a;10-7 M ),Oxytocin (10-3 U/ml) 誘發離體子宮平滑肌收縮皆有抑制作用,並證實黃芩成分- Baicalein 與Oroxylin A產生子宮鬆弛之活性與膜電位之極化、去極化有關,並配合藥理學研究使用鉀離子阻斷劑tetraethylammonium ( TEA; 1 and 10 mM ), 4-aminopyridine ( 4-AP ; 5 mM ), glipizide ( 30μM ),經實驗結果證實Baicalein 與Oroxylin A造成子宮鬆弛乃經由活化鉀離子通道之通透性,方造成子宮鬆弛,但Baicalin與Wogonin卻發現與鉀離子之作用機制無關;Baicalin與Wogonin之安胎機轉與外鈣流入及/或內鈣釋放子宮平滑肌鬆弛作用機制有相關性,且可活化β-adrenergic receptor及對cyclooxygenase具抑制作用。綜合以上結果,黃芩具有安胎作用,其安胎活性成分為Baicalin、Baicalein、Oroxylin A、Wogonin。

關鍵字

黃芩 Baicalin Baicalein Oroxylin A 安胎 Oxytocin ACh PGF2α

並列摘要


Chinese medicinal prescriptions have been used commonly in treatment of several human diseases for thousands of years in China. Huang qin, the dried root of Scutellaria baicalensis Georgi, has been used as a tocolytic agent and prescribed by Chinese medical doctors to treatment the contractive disorders in pregnant women. However, the scientific action mechanism of Huang Qin is undefined. Our preliminary data indicated that aqueous crude extract of Huang Qin exerted the significant relaxation on spontaneous constriction in 10-day pregnant rat uterus smooth muscle and IC50 values are 4.98 + 1.12 mg/ml. Therefore, studying the tocolytic activity of Huang Qin and its active components are involved in this study. Four major components including Baicalin, Baicalein, Oroxylin A, Wogonin, were isolated from Huang Qin and detected their effects on uterine contraction by in vitro tissue bath experiments. The results showed that all these four compounds performed dose-dependent relaxative effects on uterine strips precontracted by acetylcholine ( 10-6 M ), PGF2a ( 10-7 M ) and oxytocin ( 10-3 U/ml ). However, in KCl-induced contraction in uterus, Baicalein and Oroxylin A induced uterine relaxation was suppressed apparently, compared with the data of oxytocin-treated uterus, but no obvious inhibition on Baicalin and Wogonin induced relaxation. This result indicated that potassium channels and membranne potential might be involved in Baicalein and Oroxylin A induced uterine relaxation. Pharmacological studies using potassium channel antagonists such as tetraethylammonium ( TEA; 1 and 10 mM ), 4-aminopyridine ( 4-AP ; 5 mM ), glipizide ( 30μM ) were performed to demonstrate the role of potassium channels in uterine relaxation induced by these four compounds. The results showed that TEA, 4-AP and glipizise effectively block Baicalein and Oroxylin A induced uterine relaxation, but not in Baicalin and Wogonin induced relaxation. As the same part of experiment, Baicalin and Wogonin induced relaxation were attenuated byβ-receptor blocker ( Propranolol ; 10-5 M ), cyclooxyngase inhibitor ( Indomethacin ; 60 μM ). This study demonstrated that the tocolytic activity might be due to its relaxative activity components of Huang Qin and showed the effective inhibitory activities on uterine contraction. This study aims to the scientific improve Chinese herb, and the evidence suggesting the drug information of efficacy for clinic doctors. On basis of the potential pharmacological actions and active compounds isolation, a potential tocolytic agent will develop in the future.

並列關鍵字

Huang-Qui Baicalin Baicalein Oroxylin A tocolytic Oxytocin ACh PGF2α

參考文獻


3. Collaborative Group on Preterm Birth Prevention: Multicenter dradmized, controlled trial of a preterm birth prevention program. Am J Obstet Gynecol 1993;169:352-66.
4. Kristen G, Hannah ME, Hodnett ED, Ohlsson A: Tocolytics for preterm labor: a systematic review. Obstet & Gynecol 1999;94(5):869-76.
6. Saade GR, Taskin O, Belfort MA, et al: In vitro comparison of four tocolytic agents, alone and in combination. Obstet Gynecol 1994;84:374-8.
7. Rust OA, Bofill JA, Arriola RM, Andrew ME, Morrison JC: The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996;175:838-42.
8. McCormick MC: The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312:82-90.

延伸閱讀


國際替代計量